Biomarker Immunoassays in the Diagnosis of Preeclampsia: Calculating the sFlt1/PlGF Ratio Using the Cobas®e 411 Analyser-Reference-Cited by-同舟云学术

Biomarker Immunoassays in the Diagnosis of Preeclampsia: Calculating the sFlt1/PlGF Ratio Using the Cobas®e 411 Analyser

Published:2017-09-21 Issue: Volume: Page:9-26
ISSN:1064-3745
Container-title:Preeclampsia
language:
Short-container-title:

Author:

Black Carin,da Silva Costa Fabricio

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-7498-6_2

Reference26 articles.

1. Ghulmiyyah L, Sibai B (2012) Maternal mortality from preeclampsia/eclampsia. Semin Perinatol 36(1):56–59

2. Khan KS et al (2006) WHO analysis of causes of maternal death: a systematic review. Lancet 367(9516):1066–1074

3. National Collaborating Centre for W.s. and H (2010) Children’s, National Institute for Health and Clinical Excellence: guidance, in hypertension in pregnancy: the management of hypertensive disorders during pregnancy. RCOG Press Royal College of Obstetricians and Gynaecologists, London

4. WHO (2011) WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. WHO, Geneva

5. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy (2013) Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on hypertension in pregnancy. Obstet Gynecol 122(5):1122–1131

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial dysfunction in pregnancy metabolic disorders;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2020-02

2. The diagnostic efficacy of thrombelastography (TEG) in patients with preeclampsia and its association with blood coagulation;Open Life Sciences;2019-07-22